v1
Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.
Identifier:nobleid.org/w1/20260515/AC646CF4
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/AC646CF4)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims